Publications by authors named "Emily L Coleman"

Claim this Profile
E
Erythrodermic psoriasis after COVID-19 vaccination.
Nicole Trepanowski, Emily L Coleman, Gabriella Melson, Candice E Brem, Christina S Lam

JAAD Case Rep· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management of paronychia with pseudopyogenic granulomas secondary to epidermal growth factor receptor inhibitors: An assessment of topical timolol and the need for multiple medical and procedural therapies.
Brianna Olamiju, Shaman Bhullar, Emily L Coleman, Jonathan S Leventhal

J Am Acad Dermatol· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Potentially life‑threatening severe cutaneous adverse reactions associated with tyrosine kinase inhibitors (Review).
Emily L Coleman, Brianna Olamiju, Jonathan S Leventhal

Oncol Rep· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The life-threatening eruptions of immune checkpoint inhibitor therapy.
Emily L Coleman, Brianna Olamiju, Jonathan S Leventhal

Clin Dermatol· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Erythema Nodosum-like Eruption in the Setting of Sorafenib Therapy.
Emily L Coleman, Shawn E Cowper, Stacey M Stein, Jonathan S Leventhal

JAMA Dermatol· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Type 1 diabetes alters lipid handling and metabolism in human fibroblasts and peripheral blood mononuclear cells.
Albert R Jones, Emily L Coleman, Nicholas R Husni, Jude T Deeney, Forum Raval

PLoS One· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis